Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Zhejiang Huahai Pharmaceutical Co Ltd
SSE:600521
|
CN |
|
N
|
Nusantara Inti Corpora Tbk PT
IDX:UNIT
|
ID |
|
C
|
Chalice Brands Ltd.
CNSX:CHAL
|
CA |
|
Acrobiosystems Co Ltd
SZSE:301080
|
CN |
|
Vertu Motors PLC
LSE:VTU
|
UK |
|
S
|
Siamraj PCL
SET:SR
|
TH |
|
PSP Swiss Property AG
F:P7S
|
CH |
|
Cigna Corp
NYSE:CI
|
US |
|
B
|
Bonvests Holdings Ltd
SGX:B28
|
SG |
|
F
|
Fuerte Metals Corp
XTSX:FMT
|
CA |
|
Infotel SA
PAR:INF
|
FR |
|
Reko International Group Inc
XTSX:REKO
|
CA |
|
H
|
Health Empire Corporation PCL
SET:HEMP
|
TH |
|
Versus Systems Inc
NASDAQ:VS
|
CA |
|
P
|
Pan Entertainment Co Ltd
KOSDAQ:068050
|
KR |
|
Mont Royal Resources Ltd
ASX:MRZ
|
AU |
|
Daelim Trading Co Ltd
KRX:006570
|
KR |
Wall St Price Targets
Price Targets Summary
Zhejiang Huahai Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for Zhejiang Huahai Pharmaceutical Co Ltd is 18.02 CNY with a low forecast of 13.13 CNY and a high forecast of 23.1 CNY.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is Zhejiang Huahai Pharmaceutical Co Ltd's stock price target?
Price Target
18.02
CNY
According to Wall Street analysts, the average 1-year price target for Zhejiang Huahai Pharmaceutical Co Ltd is 18.02 CNY with a low forecast of 13.13 CNY and a high forecast of 23.1 CNY.
What is the Revenue forecast for Zhejiang Huahai Pharmaceutical Co Ltd?
Projected CAGR
10%
Over the last 13 years, the compound annual growth rate for Revenue has been 12%. The projected CAGR for the next 3 years is 10%.
What is the Gross Profit forecast for Zhejiang Huahai Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 2%.
What is the Operating Income forecast for Zhejiang Huahai Pharmaceutical Co Ltd?
Projected CAGR
43%
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 43%.
What is the Pre-Tax Income forecast for Zhejiang Huahai Pharmaceutical Co Ltd?
Projected CAGR
83%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 1%. The projected CAGR for the next 3 years is 83%.
What is the Net Income forecast for Zhejiang Huahai Pharmaceutical Co Ltd?
Projected CAGR
105%
Over the last 13 years, the compound annual growth rate for Net Income has been -2%. The projected CAGR for the next 3 years is 105%.
